FDA, Correlogic, Transgenomic, Lark Technologies, OpGen, Paradigm Genetics, Gene Logic, TherImmune, Third Wave, Biotage, Agencourt Bioscience, CombiMatrix | GenomeWeb

FDA Asks Correlogic to Meet On Marketing of Ovarian Cancer Test

Steve Gutman, the director of the US Food and Drug Administration's Office of In Vitro Diagnostics, has asked Correlogic Systems to discuss the marketing of the company's test for predicting ovarian cancer, GenomeWeb News, SNPtech Pharmacogenomics Reporter’s sister publication, has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.